Share Price and Basic Stock Data
Last Updated: December 17, 2025, 8:59 pm
| PEG Ratio | 2.49 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fineotex Chemical Ltd operates in the specialty chemicals sector, a space that has garnered significant attention due to its growth potential. As of the latest reports, the company recorded sales of ₹529 Cr for the trailing twelve months, reflecting a steady increase from ₹517 Cr in the previous year. This upward trend is noteworthy, particularly when considering the broader market dynamics and challenges faced by the chemical industry. The company’s sales figures have fluctuated over the past quarters, with a peak of ₹153 Cr recorded in March 2024, followed by slight declines in subsequent periods. However, the overall trajectory appears robust, suggesting that Fineotex is managing to maintain its foothold in a competitive market.
Profitability and Efficiency Metrics
Fineotex’s profitability metrics tell a compelling story of operational efficiency and financial discipline. With a reported net profit of ₹105 Cr and an impressive return on equity (ROE) of 18.4%, the company showcases its ability to generate solid returns for shareholders. The operating profit margin (OPM) stood at 24% for March 2025, indicating effective cost management and pricing strategies. Moreover, the interest coverage ratio, a staggering 141.76x, highlights the absence of debt and suggests that the company can easily cover its financial obligations. This positions Fineotex as a financially sound entity within the specialty chemicals sector, although the OPM has seen slight fluctuations, suggesting room for improvement in operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fineotex Chemical Ltd appears remarkably strong, with total borrowings reported at ₹0 Cr. This debt-free status is complemented by reserves that have grown to ₹756 Cr, reflecting prudent financial management and a focus on strengthening the company’s capital structure. The current ratio of 3.89 indicates a comfortable liquidity position, allowing the company to meet its short-term obligations without strain. The price-to-book value ratio at 3.60x, while slightly elevated, is not uncommon in the specialty chemicals sector, where growth potential often commands a premium. Overall, these figures suggest that Fineotex is in a favorable position to weather economic fluctuations and invest in growth opportunities.
Shareholding Pattern and Investor Confidence
Investor confidence in Fineotex is reflected in its shareholding pattern, where promoters hold a substantial 62.89% stake. This level of insider ownership typically indicates a strong commitment to the company’s long-term vision. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold relatively modest stakes of 2.16% and 1.55%, respectively. This could suggest potential for greater institutional interest, especially as the company continues to demonstrate financial stability and growth. The increase in the number of shareholders to 1,53,373 also indicates a growing retail interest, which can be a positive signal for the company’s future performance. However, the relatively low institutional ownership might raise questions about broader market perception and confidence in the stock.
Outlook, Risks, and Final Insight
Looking ahead, Fineotex Chemical Ltd seems well-positioned to leverage its strengths, but it must navigate certain risks. The strong financial metrics and operational efficiency suggest a solid foundation, yet the chemical industry is often susceptible to fluctuations in raw material prices and regulatory changes, which could impact profitability. Additionally, while the absence of debt is a strength, it also raises questions about the company’s growth strategy and its ability to capitalize on high-return investments. For investors, the key will be balancing the attractive financials against potential sector risks. As Fineotex continues to evolve, maintaining operational efficiency and adapting to market dynamics will be crucial in sustaining its growth trajectory and maximizing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 386 Cr. | 42.2 | 83.5/41.2 | 24.0 | 20.5 | 0.95 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.9 Cr. | 61.0 | 96.5/56.0 | 14.3 | 89.6 | 1.64 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.2 Cr. | 708 | 956/600 | 22.2 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,414 Cr. | 75.3 | 111/74.2 | 22.6 | 22.0 | 0.66 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 653 Cr. | 259 | 439/241 | 23.4 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,725.64 Cr | 722.37 | 66.68 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 136 | 134 | 109 | 138 | 132 | 145 | 138 | 153 | 142 | 146 | 126 | 120 | 137 |
| Expenses | 110 | 109 | 81 | 105 | 101 | 107 | 98 | 115 | 107 | 109 | 92 | 99 | 112 |
| Operating Profit | 26 | 25 | 29 | 33 | 32 | 38 | 40 | 38 | 35 | 36 | 34 | 21 | 25 |
| OPM % | 19% | 19% | 26% | 24% | 24% | 26% | 29% | 25% | 25% | 25% | 27% | 18% | 18% |
| Other Income | 1 | 2 | 2 | 2 | 4 | 4 | 5 | 4 | 5 | 7 | 5 | 8 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 3 |
| Profit before tax | 26 | 26 | 29 | 33 | 34 | 40 | 44 | 40 | 38 | 41 | 36 | 26 | 31 |
| Tax % | 22% | 21% | 23% | 22% | 22% | 22% | 24% | 24% | 22% | 21% | 24% | 24% | 21% |
| Net Profit | 20 | 21 | 22 | 26 | 26 | 31 | 33 | 30 | 29 | 32 | 28 | 20 | 25 |
| EPS in Rs | 1.79 | 1.86 | 2.00 | 2.33 | 2.32 | 2.83 | 2.95 | 2.72 | 2.57 | 2.78 | 2.41 | 1.74 | 2.17 |
Last Updated: August 20, 2025, 10:55 am
Below is a detailed analysis of the quarterly data for Fineotex Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 137.00 Cr.. The value appears strong and on an upward trend. It has increased from 120.00 Cr. (Mar 2025) to 137.00 Cr., marking an increase of 17.00 Cr..
- For Expenses, as of Jun 2025, the value is 112.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 99.00 Cr. (Mar 2025) to 112.00 Cr., marking an increase of 13.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 4.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
- For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 21.00%, marking a decrease of 3.00%.
- For Net Profit, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 5.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.17. The value appears strong and on an upward trend. It has increased from 1.74 (Mar 2025) to 2.17, marking an increase of 0.43.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 102 | 110 | 127 | 141 | 182 | 196 | 219 | 368 | 517 | 569 | 533 | 520 |
| Expenses | 77 | 85 | 82 | 98 | 111 | 148 | 162 | 178 | 297 | 404 | 421 | 406 | 409 |
| Operating Profit | 9 | 16 | 28 | 29 | 30 | 34 | 35 | 41 | 71 | 113 | 148 | 127 | 112 |
| OPM % | 11% | 16% | 26% | 23% | 21% | 19% | 18% | 19% | 19% | 22% | 26% | 24% | 21% |
| Other Income | 3 | 5 | 2 | 10 | 5 | 1 | -11 | 17 | 6 | 7 | 17 | 24 | 29 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 6 | 9 | 10 |
| Profit before tax | 11 | 20 | 29 | 38 | 34 | 34 | 22 | 56 | 73 | 115 | 158 | 141 | 130 |
| Tax % | 30% | 28% | 31% | 24% | 29% | 28% | 35% | 20% | 22% | 22% | 23% | 23% | |
| Net Profit | 8 | 15 | 20 | 29 | 24 | 24 | 14 | 45 | 57 | 90 | 121 | 109 | 99 |
| EPS in Rs | 0.06 | 0.11 | 0.16 | 0.23 | 0.20 | 0.20 | 0.12 | 0.38 | 0.50 | 0.80 | 1.08 | 0.94 | 0.86 |
| Dividend Payout % | 9% | 9% | 13% | 4% | 10% | 5% | 4% | 8% | 8% | 10% | 15% | 8% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 87.50% | 33.33% | 45.00% | -17.24% | 0.00% | -41.67% | 221.43% | 26.67% | 57.89% | 34.44% | -9.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -54.17% | 11.67% | -62.24% | 17.24% | -41.67% | 263.10% | -194.76% | 31.23% | -23.45% | -44.36% |
Fineotex Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 13% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 40% |
| 3 Years: | 25% |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 50% |
| 3 Years: | -13% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 24% |
| 3 Years: | 24% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 4:00 am
Balance Sheet
Last Updated: December 4, 2025, 1:14 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 23 | 23 |
| Reserves | 54 | 54 | 69 | 90 | 113 | 137 | 147 | 187 | 240 | 327 | 425 | 708 | 756 |
| Borrowings | 4 | 2 | 3 | 1 | 5 | 2 | 3 | 3 | 2 | 7 | 5 | 0 | 0 |
| Other Liabilities | 19 | 23 | 20 | 26 | 21 | 34 | 35 | 54 | 75 | 67 | 96 | 83 | 98 |
| Total Liabilities | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 878 |
| Fixed Assets | 14 | 18 | 19 | 27 | 29 | 36 | 41 | 59 | 84 | 99 | 141 | 179 | 198 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 21 | 8 |
| Investments | 16 | 29 | 39 | 47 | 55 | 48 | 52 | 32 | 17 | 89 | 147 | 330 | 348 |
| Other Assets | 58 | 54 | 56 | 66 | 77 | 110 | 114 | 171 | 238 | 234 | 260 | 284 | 323 |
| Total Assets | 88 | 101 | 114 | 140 | 161 | 195 | 208 | 267 | 339 | 423 | 548 | 815 | 878 |
Below is a detailed analysis of the balance sheet data for Fineotex Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 23.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00 Cr..
- For Reserves, as of Sep 2025, the value is 756.00 Cr.. The value appears strong and on an upward trend. It has increased from 708.00 Cr. (Mar 2025) to 756.00 Cr., marking an increase of 48.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 98.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 878.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 815.00 Cr. (Mar 2025) to 878.00 Cr., marking an increase of 63.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 198.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 198.00 Cr., marking an increase of 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 348.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 348.00 Cr., marking an increase of 18.00 Cr..
- For Other Assets, as of Sep 2025, the value is 323.00 Cr.. The value appears strong and on an upward trend. It has increased from 284.00 Cr. (Mar 2025) to 323.00 Cr., marking an increase of 39.00 Cr..
- For Total Assets, as of Sep 2025, the value is 878.00 Cr.. The value appears strong and on an upward trend. It has increased from 815.00 Cr. (Mar 2025) to 878.00 Cr., marking an increase of 63.00 Cr..
Notably, the Reserves (756.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 5.00 | 14.00 | 25.00 | 28.00 | 25.00 | 32.00 | 32.00 | 38.00 | 69.00 | 106.00 | 143.00 | 127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 80 | 84 | 84 | 72 | 98 | 100 | 138 | 110 | 72 | 89 | 79 |
| Inventory Days | 68 | 56 | 66 | 70 | 97 | 84 | 66 | 79 | 98 | 53 | 55 | 75 |
| Days Payable | 81 | 75 | 75 | 82 | 50 | 70 | 73 | 101 | 96 | 53 | 79 | 66 |
| Cash Conversion Cycle | 79 | 60 | 75 | 72 | 119 | 112 | 93 | 116 | 111 | 72 | 64 | 88 |
| Working Capital Days | 80 | 58 | 73 | 73 | 114 | 118 | 107 | 136 | 125 | 71 | 76 | 104 |
| ROCE % | 15% | 21% | 31% | 35% | 26% | 22% | 20% | 28% | 30% | 36% | 39% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 14,829,218 | 0.05 | 37.33 | 17,788,190 | 2025-12-15 03:04:08 | -16.63% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.53 | 10.82 | 7.97 | 4.97 | 3.84 |
| Diluted EPS (Rs.) | 9.53 | 10.82 | 7.97 | 4.97 | 3.84 |
| Cash EPS (Rs.) | 10.34 | 11.47 | 8.47 | 5.36 | 4.16 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.83 | 40.95 | 32.12 | 24.32 | 19.51 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.83 | 40.95 | 32.12 | 24.32 | 19.51 |
| Revenue From Operations / Share (Rs.) | 46.55 | 51.37 | 46.68 | 33.25 | 19.73 |
| PBDIT / Share (Rs.) | 13.23 | 14.89 | 10.83 | 6.93 | 5.24 |
| PBIT / Share (Rs.) | 12.42 | 14.35 | 10.44 | 6.70 | 5.11 |
| PBT / Share (Rs.) | 12.33 | 14.23 | 10.37 | 6.62 | 5.04 |
| Net Profit / Share (Rs.) | 9.53 | 10.93 | 8.09 | 5.14 | 4.02 |
| NP After MI And SOA / Share (Rs.) | 9.44 | 10.82 | 7.97 | 4.98 | 3.85 |
| PBDIT Margin (%) | 28.41 | 28.98 | 23.19 | 20.83 | 26.57 |
| PBIT Margin (%) | 26.68 | 27.92 | 22.36 | 20.15 | 25.89 |
| PBT Margin (%) | 26.48 | 27.69 | 22.20 | 19.90 | 25.56 |
| Net Profit Margin (%) | 20.47 | 21.27 | 17.32 | 15.44 | 20.39 |
| NP After MI And SOA Margin (%) | 20.28 | 21.05 | 17.08 | 14.98 | 19.49 |
| Return on Networth / Equity (%) | 14.79 | 26.79 | 25.32 | 21.04 | 20.34 |
| Return on Capital Employeed (%) | 19.03 | 34.63 | 32.21 | 27.34 | 26.03 |
| Return On Assets (%) | 13.28 | 21.85 | 20.89 | 16.25 | 15.94 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 0.78 | 1.17 | 1.36 | 1.21 | 0.61 |
| Current Ratio (X) | 3.89 | 3.20 | 3.51 | 3.41 | 3.30 |
| Quick Ratio (X) | 2.93 | 2.64 | 2.77 | 2.53 | 2.72 |
| Inventory Turnover Ratio (X) | 9.31 | 6.98 | 6.37 | 4.92 | 3.46 |
| Dividend Payout Ratio (NP) (%) | 4.23 | 18.48 | 5.01 | 6.02 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.90 | 17.60 | 4.78 | 5.75 | 0.00 |
| Earning Retention Ratio (%) | 95.77 | 81.52 | 94.99 | 93.98 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.10 | 82.40 | 95.22 | 94.25 | 0.00 |
| Interest Coverage Ratio (X) | 141.76 | 123.87 | 146.13 | 83.11 | 80.21 |
| Interest Coverage Ratio (Post Tax) (X) | 103.17 | 91.90 | 110.15 | 62.62 | 62.55 |
| Enterprise Value (Cr.) | 2598.43 | 4052.88 | 2534.05 | 1965.68 | 704.98 |
| EV / Net Operating Revenue (X) | 4.87 | 7.12 | 4.90 | 5.34 | 3.23 |
| EV / EBITDA (X) | 17.15 | 24.57 | 21.13 | 25.62 | 12.14 |
| MarketCap / Net Operating Revenue (X) | 4.94 | 7.17 | 4.99 | 5.42 | 3.34 |
| Retention Ratios (%) | 95.76 | 81.51 | 94.98 | 93.97 | 0.00 |
| Price / BV (X) | 3.60 | 9.13 | 7.40 | 7.61 | 3.48 |
| Price / Net Operating Revenue (X) | 4.94 | 7.17 | 4.99 | 5.42 | 3.34 |
| EarningsYield | 0.04 | 0.02 | 0.03 | 0.02 | 0.05 |
After reviewing the key financial ratios for Fineotex Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.53, marking a decrease of 1.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.53, marking a decrease of 1.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 11.47 (Mar 24) to 10.34, marking a decrease of 1.13.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.83. It has increased from 40.95 (Mar 24) to 63.83, marking an increase of 22.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.83. It has increased from 40.95 (Mar 24) to 63.83, marking an increase of 22.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.55. It has decreased from 51.37 (Mar 24) to 46.55, marking a decrease of 4.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.23. This value is within the healthy range. It has decreased from 14.89 (Mar 24) to 13.23, marking a decrease of 1.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 12.42. This value is within the healthy range. It has decreased from 14.35 (Mar 24) to 12.42, marking a decrease of 1.93.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.33. This value is within the healthy range. It has decreased from 14.23 (Mar 24) to 12.33, marking a decrease of 1.90.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.53. This value is within the healthy range. It has decreased from 10.93 (Mar 24) to 9.53, marking a decrease of 1.40.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.44. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.44, marking a decrease of 1.38.
- For PBDIT Margin (%), as of Mar 25, the value is 28.41. This value is within the healthy range. It has decreased from 28.98 (Mar 24) to 28.41, marking a decrease of 0.57.
- For PBIT Margin (%), as of Mar 25, the value is 26.68. This value exceeds the healthy maximum of 20. It has decreased from 27.92 (Mar 24) to 26.68, marking a decrease of 1.24.
- For PBT Margin (%), as of Mar 25, the value is 26.48. This value is within the healthy range. It has decreased from 27.69 (Mar 24) to 26.48, marking a decrease of 1.21.
- For Net Profit Margin (%), as of Mar 25, the value is 20.47. This value exceeds the healthy maximum of 10. It has decreased from 21.27 (Mar 24) to 20.47, marking a decrease of 0.80.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 20.28. This value exceeds the healthy maximum of 20. It has decreased from 21.05 (Mar 24) to 20.28, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.79. This value is below the healthy minimum of 15. It has decreased from 26.79 (Mar 24) to 14.79, marking a decrease of 12.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.03. This value is within the healthy range. It has decreased from 34.63 (Mar 24) to 19.03, marking a decrease of 15.60.
- For Return On Assets (%), as of Mar 25, the value is 13.28. This value is within the healthy range. It has decreased from 21.85 (Mar 24) to 13.28, marking a decrease of 8.57.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 1.17 (Mar 24) to 0.78, marking a decrease of 0.39.
- For Current Ratio (X), as of Mar 25, the value is 3.89. This value exceeds the healthy maximum of 3. It has increased from 3.20 (Mar 24) to 3.89, marking an increase of 0.69.
- For Quick Ratio (X), as of Mar 25, the value is 2.93. This value exceeds the healthy maximum of 2. It has increased from 2.64 (Mar 24) to 2.93, marking an increase of 0.29.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.31. This value exceeds the healthy maximum of 8. It has increased from 6.98 (Mar 24) to 9.31, marking an increase of 2.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.23. This value is below the healthy minimum of 20. It has decreased from 18.48 (Mar 24) to 4.23, marking a decrease of 14.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 20. It has decreased from 17.60 (Mar 24) to 3.90, marking a decrease of 13.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.77. This value exceeds the healthy maximum of 70. It has increased from 81.52 (Mar 24) to 95.77, marking an increase of 14.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.10. This value exceeds the healthy maximum of 70. It has increased from 82.40 (Mar 24) to 96.10, marking an increase of 13.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 141.76. This value is within the healthy range. It has increased from 123.87 (Mar 24) to 141.76, marking an increase of 17.89.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 103.17. This value is within the healthy range. It has increased from 91.90 (Mar 24) to 103.17, marking an increase of 11.27.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,598.43. It has decreased from 4,052.88 (Mar 24) to 2,598.43, marking a decrease of 1,454.45.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.87. This value exceeds the healthy maximum of 3. It has decreased from 7.12 (Mar 24) to 4.87, marking a decrease of 2.25.
- For EV / EBITDA (X), as of Mar 25, the value is 17.15. This value exceeds the healthy maximum of 15. It has decreased from 24.57 (Mar 24) to 17.15, marking a decrease of 7.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 24) to 4.94, marking a decrease of 2.23.
- For Retention Ratios (%), as of Mar 25, the value is 95.76. This value exceeds the healthy maximum of 70. It has increased from 81.51 (Mar 24) to 95.76, marking an increase of 14.25.
- For Price / BV (X), as of Mar 25, the value is 3.60. This value exceeds the healthy maximum of 3. It has decreased from 9.13 (Mar 24) to 3.60, marking a decrease of 5.53.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.94. This value exceeds the healthy maximum of 3. It has decreased from 7.17 (Mar 24) to 4.94, marking a decrease of 2.23.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fineotex Chemical Ltd:
- Net Profit Margin: 20.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.03% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.79% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 103.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.5 (Industry average Stock P/E: 66.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | 42 & 43, Manorama Chambers, Mumbai Maharashtra 400050 | investor.relations@fineotex.com http://www.fineotex.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Surendrakumar Tibrewala | Chairman & Managing Director |
| Mr. Sanjay Tibrewala | Executive Director & CFO |
| Mrs. Aarti Jhunjhunwala | Executive Director |
| Mrs. Bindu Shah | Independent Director |
| Dr. Sunil Waghmare | Independent Director |
| Mr. Alok Dhanuka | Independent Director |
| Mr. Navin Mittal | Independent Director |
| Dr. Amit Prabhakar Pratap | Independent Director |
FAQ
What is the intrinsic value of Fineotex Chemical Ltd?
Fineotex Chemical Ltd's intrinsic value (as of 17 December 2025) is 28.62 which is 18.26% higher the current market price of 24.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,806 Cr. market cap, FY2025-2026 high/low of 35.8/19.2, reserves of ₹756 Cr, and liabilities of 878 Cr.
What is the Market Cap of Fineotex Chemical Ltd?
The Market Cap of Fineotex Chemical Ltd is 2,806 Cr..
What is the current Stock Price of Fineotex Chemical Ltd as on 17 December 2025?
The current stock price of Fineotex Chemical Ltd as on 17 December 2025 is 24.2.
What is the High / Low of Fineotex Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fineotex Chemical Ltd stocks is 35.8/19.2.
What is the Stock P/E of Fineotex Chemical Ltd?
The Stock P/E of Fineotex Chemical Ltd is 28.5.
What is the Book Value of Fineotex Chemical Ltd?
The Book Value of Fineotex Chemical Ltd is 6.80.
What is the Dividend Yield of Fineotex Chemical Ltd?
The Dividend Yield of Fineotex Chemical Ltd is 0.33 %.
What is the ROCE of Fineotex Chemical Ltd?
The ROCE of Fineotex Chemical Ltd is 23.8 %.
What is the ROE of Fineotex Chemical Ltd?
The ROE of Fineotex Chemical Ltd is 18.4 %.
What is the Face Value of Fineotex Chemical Ltd?
The Face Value of Fineotex Chemical Ltd is 1.00.